Takeda Pharmaceutical Company Limited (TKDA) — Capital Reinvestment Ratio
Takeda Pharmaceutical Company Limited (TKDA) has a Capital Reinvestment Ratio of 0.60x as of December 2025, meaning it reinvests 1% of its operating cash flow (€373.25 Billion) in capital expenditures (€222.37 Billion). See how much free cash does Takeda Pharmaceutical Company Limited generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Takeda Pharmaceutical Company Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Takeda Pharmaceutical Company Limited's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Takeda Pharmaceutical Company Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Takeda Pharmaceutical Company Limited from 2017 to 2025. For live market cap and broader valuation context, see TKDA company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | €1.06 Trillion | €379.62 Billion | ▼ -46.5% |
| 2024 | 0.67x | €716.34 Billion | €480.73 Billion | ▲ +3.5% |
| 2023 | 0.65x | €977.16 Billion | €633.69 Billion | ▲ +490.9% |
| 2022 | 0.11x | €1.12 Trillion | €123.25 Billion | ▼ -0.2% |
| 2021 | 0.11x | €1.01 Trillion | €111.21 Billion | ▼ -42.0% |
| 2020 | 0.19x | €669.75 Billion | €127.08 Billion | ▼ -19.8% |
| 2019 | 0.24x | €328.48 Billion | €77.68 Billion | ▲ +33.4% |
| 2018 | 0.18x | €377.85 Billion | €67.00 Billion | ▼ -24.8% |
| 2017 | 0.24x | €261.36 Billion | €61.66 Billion | — |